1. NSAIDs appear to increase the risk of renal disease …

   Newsletter Article 30 January 2013 Pages: 1 - 1

2. … and can induce CNS effects

   Newsletter Article 30 January 2013 Pages: 1 - 1

3. Long term animal toxicology studies should not be needed in the development of new antirheumatics

   Newsletter Article 30 January 2013 Pages: 2 - 2

4. Lonidamine does not share the life-threatening effects of other antineoplastics

   Newsletter Article 30 January 2013 Pages: 2 - 3

5. An overview of digoxin toxicity

   Newsletter Article 30 January 2013 Pages: 3 - 4

6. The evidence for associations between certain cancers and OC use is not convincing

   Newsletter Article 30 January 2013 Pages: 4 - 4

7. Amiodarone

   Newsletter Article 30 January 2013 Pages: 5 - 5

8. Amitriptyline see Hydroxychloroquine/amitriptyline

   Newsletter Article 30 January 2013 Pages: 5 - 5

9. Anticonvulsants

   Newsletter Article 30 January 2013 Pages: 5 - 5

10. Anticonvulsants interaction

    Newsletter Article 30 January 2013 Pages: 5 - 5

11. Beta blockers see Diltiazem interaction

    Newsletter Article 30 January 2013 Pages: 5 - 5

12. Budesonide

    Newsletter Article 30 January 2013 Pages: 5 - 5

13. Busulfan

    Newsletter Article 30 January 2013 Pages: 5 - 5

14. Calcium antagonists see Anticonvulsants interaction

    Newsletter Article 30 January 2013 Pages: 5 - 5

15. Captopril

    Newsletter Article 30 January 2013 Pages: 6 - 6

16. Carbamazepine

    Newsletter Article 30 January 2013 Pages: 6 - 6

17. Cinchophen

    Newsletter Article 30 January 2013 Pages: 6 - 6

18. Cisplatin/mitomycin/vindesine

    Newsletter Article 30 January 2013 Pages: 6 - 6

19. Clonazepam see Phenelzine interaction

    Newsletter Article 30 January 2013 Pages: 6 - 6

20. Clozapine

    Newsletter Article 30 January 2013 Pages: 6 - 6

21. Cocaine abuse

    Newsletter Article 30 January 2013 Pages: 6 - 6

22. Diamorphine abuse

    Newsletter Article 30 January 2013 Pages: 6 - 6

23. Digoxin see Sucralfate interaction

    Newsletter Article 30 January 2013 Pages: 6 - 6

24. Diltiazem interaction

    Newsletter Article 30 January 2013 Pages: 6 - 7

25. Diuretics

    Newsletter Article 30 January 2013 Pages: 7 - 7

26. Enalapril

    Newsletter Article 30 January 2013 Pages: 7 - 7

27. Epoetin

    Newsletter Article 30 January 2013 Pages: 7 - 7

28. Etretinate

    Newsletter Article 30 January 2013 Pages: 7 - 7

29. Fluindione see Propafenone interaction

    Newsletter Article 30 January 2013 Pages: 7 - 7

30. Fluoxetine

    Newsletter Article 30 January 2013 Pages: 7 - 7

31. Flurbiprofen

    Newsletter Article 30 January 2013 Pages: 8 - 8

32. Flutamide

    Newsletter Article 30 January 2013 Pages: 8 - 8

33. Heparin

    Newsletter Article 30 January 2013 Pages: 8 - 8

34. Hydroxychloroquine/amitriptyline

    Newsletter Article 30 January 2013 Pages: 8 - 8

35. Influenza virus vaccine

    Newsletter Article 30 January 2013 Pages: 8 - 8

36. Insulin abuse

    Newsletter Article 30 January 2013 Pages: 8 - 8

37. Interferon alpha

    Newsletter Article 30 January 2013 Pages: 8 - 9

38. ME 2303

    Newsletter Article 30 January 2013 Pages: 9 - 9

39. Mepivacaine

    Newsletter Article 30 January 2013 Pages: 9 - 9

40. Methylergometrine

    Newsletter Article 30 January 2013 Pages: 9 - 9

41. Methylprednisolone

    Newsletter Article 30 January 2013 Pages: 9 - 9

42. Mitomycin see Cisplatin/mitomycin/vindesine

    Newsletter Article 30 January 2013 Pages: 9 - 9

43. NSAIDs

    Newsletter Article 30 January 2013 Pages: 9 - 10

44. Oral contraceptives

    Newsletter Article 30 January 2013 Pages: 10 - 10

45. Pethidine interaction

    Newsletter Article 30 January 2013 Pages: 10 - 10

46. Phenazone

    Newsletter Article 30 January 2013 Pages: 10 - 10

47. Phenelzine interaction

    Newsletter Article 30 January 2013 Pages: 10 - 10

48. Phytomenadione

    Newsletter Article 30 January 2013 Pages: 10 - 10

49. Propafenone interaction

    Newsletter Article 30 January 2013 Pages: 10 - 10

50. Pyrantel

    Newsletter Article 30 January 2013 Pages: 10 - 11